CINECA IRIS Institutional Research Information System

FORNAI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.544
AS - Asia 6.251
EU - Europa 5.993
SA - Sud America 944
AF - Africa 347
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 5
Totale 27.109
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.166
IT - Italia 2.442
SG - Singapore 2.016
CN - Cina 1.812
HK - Hong Kong 1.085
SE - Svezia 835
BR - Brasile 801
DE - Germania 569
BG - Bulgaria 431
VN - Vietnam 369
GB - Regno Unito 348
FI - Finlandia 277
CA - Canada 271
TR - Turchia 267
RU - Federazione Russa 262
AT - Austria 207
IN - India 153
UA - Ucraina 149
CI - Costa d'Avorio 148
FR - Francia 123
KR - Corea 123
JP - Giappone 84
NL - Olanda 81
PL - Polonia 66
MX - Messico 62
AR - Argentina 60
CH - Svizzera 50
SN - Senegal 47
BD - Bangladesh 44
BE - Belgio 44
PK - Pakistan 41
IQ - Iraq 37
NG - Nigeria 35
UZ - Uzbekistan 31
ZA - Sudafrica 30
IR - Iran 27
ID - Indonesia 24
ES - Italia 22
VE - Venezuela 21
MA - Marocco 20
EC - Ecuador 19
AU - Australia 18
SA - Arabia Saudita 18
EG - Egitto 15
CZ - Repubblica Ceca 14
LT - Lituania 13
AE - Emirati Arabi Uniti 12
AZ - Azerbaigian 12
CO - Colombia 12
PH - Filippine 12
PY - Paraguay 12
KE - Kenya 11
MY - Malesia 11
TW - Taiwan 11
CL - Cile 9
DZ - Algeria 9
IE - Irlanda 9
PT - Portogallo 9
JM - Giamaica 8
PA - Panama 8
TN - Tunisia 8
BJ - Benin 7
HN - Honduras 7
JO - Giordania 7
KZ - Kazakistan 7
NO - Norvegia 7
OM - Oman 7
AL - Albania 6
HU - Ungheria 6
KG - Kirghizistan 6
LB - Libano 6
NZ - Nuova Zelanda 6
IL - Israele 5
TT - Trinidad e Tobago 5
DO - Repubblica Dominicana 4
GH - Ghana 4
NP - Nepal 4
PE - Perù 4
QA - Qatar 4
RO - Romania 4
UY - Uruguay 4
AO - Angola 3
BY - Bielorussia 3
DK - Danimarca 3
EU - Europa 3
GD - Grenada 3
GR - Grecia 3
LV - Lettonia 3
PS - Palestinian Territory 3
RS - Serbia 3
BN - Brunei Darussalam 2
BS - Bahamas 2
CG - Congo 2
GE - Georgia 2
GT - Guatemala 2
MK - Macedonia 2
SV - El Salvador 2
TH - Thailandia 2
TJ - Tagikistan 2
UG - Uganda 2
Totale 27.087
Salva come PNG Salva come JPEG
Città #
Ashburn 1.430
Woodbridge 1.125
Fairfield 1.106
Hong Kong 1.063
Singapore 1.042
Ann Arbor 959
Dallas 951
Houston 868
Chandler 821
Santa Clara 774
Milan 487
Seattle 438
Sofia 427
Wilmington 426
Shanghai 419
Beijing 392
Cambridge 387
Serra 382
New York 304
Boardman 256
Los Angeles 215
Ottawa 200
Princeton 184
Jacksonville 162
Lawrence 160
Abidjan 148
Pisa 148
Izmir 147
Vienna 146
Medford 139
Hefei 133
Florence 128
Munich 122
Dong Ket 112
Nanjing 108
Des Moines 105
Seoul 101
London 96
Rome 95
Chicago 84
Istanbul 82
Buffalo 78
Helsinki 76
Bremen 75
Redondo Beach 74
São Paulo 70
Frankfurt am Main 67
Dearborn 62
San Jose 62
Tokyo 60
Nanchang 56
Turku 54
Council Bluffs 53
Lucca 53
Ho Chi Minh City 52
Dakar 47
Lappeenranta 45
Lancaster 44
Ogden 43
Falls Church 42
Brussels 41
Warsaw 41
Bern 40
San Diego 40
Columbus 38
Hanoi 37
Redwood City 37
The Dalles 34
Lagos 33
Nuremberg 31
Pune 30
Jüchen 29
Tashkent 28
Washington 28
Montignoso 27
Hebei 26
Marseille 26
Boulder 25
Phoenix 25
Tianjin 25
Atlanta 24
Kunming 23
Livorno 23
Fuzhou 22
Guangzhou 22
Montreal 22
Rio de Janeiro 22
Toronto 22
Brooklyn 21
Chennai 21
Naples 21
Belo Horizonte 19
Norwalk 19
Brasília 18
Changsha 18
Kent 18
Porto Alegre 18
Shenzhen 18
Hangzhou 17
Poplar 17
Totale 19.031
Salva come PNG Salva come JPEG
Nome #
Derivati isoindolici come attivatori di AMPK 504
Preparation of isoindoline derivatives for use as AMPK activators 317
An integrated assessment of histopathological changes of the enteric neuromuscular compartment in experimental colitis. 286
Exploiting the Pyrazolo[3,4-d]pyrimidin-4-one ring system as a useful template to obtain potent adenosine deaminase inhibitors, 258
COMPOSTI INIBITORI DELL’INFLAMMASOMA NLRP3 E LORO USO 247
Protective Role of Flavonoids Against Colonic Motor Dysfunctions Associated with High Fat Diet-Induced Obesity 239
Quality of adverse drug reaction (QADRA) reports: an algorithm to appraise the efficiency of spontaneous reporting systems in pharmacovigilance 234
Derivati benzofuranici come attivatori di AMPK 226
Protective effects of Saccharomyces boulardii CNCM I-745 Against Nonsteroidal anti-inflammatory drug-induced intestinal injury 219
Anti-inflammatory effect of a novel adenosine deaminase inhibitor in experimental colitis 217
Pathophysiology of NSAID-associated intestinal lesions in the rat: Luminal bacteria and mucosal inflammation as targets for prevention 209
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation 206
A2a receptors mediate inhibitory effects of adenosine on colonic motility in the presence of experimental colitis 197
Emerging role of Cyclooxygenase isoforms in the control of gastrointestinal neuromuscular functions 197
Constitutive expression of cyclooxygenase-2 in the neuromuscular compartment of normal human colon 196
Colonic dysmotility associated with high-fat diet-induced obesity: Role of enteric glia 194
Colonic motor dysfunctions in a mouse model of high-fat diet-induced obesity: an involvement of A2B adenosine receptors 192
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients 192
Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition 190
Small bowel protection against NSAID-injury in rats: Effect of rifaximin, a poorly absorbed, GI targeted, antibiotic 187
Safety of MF-59 adjuvanted vaccine for pandemic influenza: results of the vaccination campaign in an Italian health district 185
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome 183
Cyclooxygenase inhibitors modulate pro-fibrotic signalling mediated by TGFbeta in experimental colitis 182
NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same? 181
A1 and A2a receptors mediate inhibitory rffects of adenosine on the motor activity of human colon 180
The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity 180
Prodromal Intestinal Events in Alzheimer's Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition 180
Clinical efficacy of esomeprazole in the prevention and healing of digestive toxicity associated with non-steroidal anti-inflammatory drugs in elderly patients 179
Inducible Nitric Oxide Synthase is involved in endothelial dysfunction of mesenteric small arteries from hypothyroid rats 179
Telogen effluvium following bivalent human papilloma virus vaccine administration: a report of two cases 178
Role of coxibs in the strategies for gastrointestinal protection in patients requiring chronic non-steroidal anti-inflammatory therapy 178
Enteric protective effects of the combination Bifidobacterium longum and lactoferrin in a rat model of diclofenac-induced intestinal injury. 177
Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 176
Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects 176
The AMPK enzyme-complex: from the regulation of cellular energy homeostasis to a possible new molecular target in the management of chronic inflammatory disorders 174
Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation 174
Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management 173
Neuromodulation of colonic motility by cycloxygenase isoforms in the presence of experimental bowel inflammation 172
Differential role of cyclooxygenase 1 and 2 isoforms in the modulation of colonic neuromuscular function in experimental inflammation 171
Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice 171
Efficay and tolerability of meloxicam, a COX-2 preferential nonsteroidal anti-inflammatory drug: a review 171
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders 170
AMPK Activators as Novel Drug Candidates for the Treatment of Inflammatory Bowel Diseases 170
Expression pattern of COX isoforms in experimental models of enteric and airway inflammation 169
Dietary Supplement, Containing the Dry Extract of Curcumin, Emblica and Cassia, Counteracts Intestinal Inflammation and Enteric Dysmotility Associated with Obesity 168
Adverse reactions to oncologic drugs: spontaneous reporting and signal detection 168
Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications? 168
Preclinical development of fa5, a novel amp-activated protein kinase (Ampk) activator as an innovative drug for the management of bowel inflammation 168
Response to Endothelial nitric oxide synthase, cyclooxygenase-2, and essential hypertension: is there an interaction? 167
Effects of esomeprazole on healing of non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: characterization of molecular mechanisms 166
Genetic polymorphisms of thiopurine S-methyltransferase in a cohort of patients with systemic autoimmune diseases 166
Allopurinol adherence among patients with gout: an Italian general practice database study 166
Characterization of mechanisms underlying the effects of esomeprazole on the impairment of gastric ulcer healing with addition of NSAID treatment 165
Effects of pantoprazole on ulcer healing delay associated with NSAID treatment 165
Dietary Supplementation with the Probiotic SF68 Reinforces Intestinal Epithelial Barrier in Obese Mice by Improving Butyrate Bioavailability 164
Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity 164
Evaluation of cytokine levels as putative biomarkers to predict the pharmacological response to biologic therapy in inflammatory bowel diseases 164
Role of A2a adenosine in the regulation of colonic motility in normal human colon 163
Canonical and Non-Canonical Activation of NLRP3 Inflammasome at the Crossroad between Immune Tolerance and Intestinal Inflammation 163
Switching off CD73: a way to boost the activity of conventional and targeted antineoplastic therapies 161
Mechanisms underlying the non-anticoagulant effects of apixaban and dabigatran on the integrity of intestinal mucosa: a comparative pre-clinical study. 160
Preparation of benzofuran derivatives for use as AMPK activators 160
Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab 160
Role of cyclooxygenase isoforms in the altered excitatory motor pathways of human colon with diverticular disease 160
Effects of selective cyclooxygenase-2 inhibitors on healing of experimental gastric ulcers and mucosal expression of cyclooxygenase isoforms 159
Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats 159
Effects of selective cyclooxygenase-2 inhibitors on healing of experimental gastric ulcers and mucosal expression of cyclooxygenase isoforms 158
Reduced modulating actions of adenosine pathways on enteric neuromuscular activity in experimental colitis 158
Control of enteric neuromuscular functions by purinergic A3 receptors in normal rat distal colon and experimental bowel inflammation 158
Glial A2B Adenosine Receptors Modulate Abnormal Tachykininergic Responses and Prevent Enteric Inflammation Associated with High Fat Diet-Induced Obesity 157
Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage 156
Donepezil improves vascular function in a mouse model of Alzheimer's disease 156
Differential role of A1 and A2a purinergic receptors in the control of colonic neurumuscular function in the presence of experimental colitis 155
The role of purinergic pathways in the pathophysiology of gut diseases: pharmacological modulation and potential therapeutic applications 155
Intestinal dysfunction in Parkinson's disease: Lessons learned from translational studies and experimental models 155
Transient acute liver failure complicating transurethral resection syndrome 154
Adenosine and inflammation: what's new on the horizon? 153
NLRP3 at the crossroads between immune/inflammatory responses and enteric neuroplastic remodelling in a mouse model of diet-induced obesity 153
The blockade of adenosine deaminase ameliorates chronic experimental colitis through the recruitment of adenosine A2A and A3 receptors 152
Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders 152
Managing Obesity and Related Comorbidities: A Potential Pharmacological Target in the Adenosine System? 152
Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review 150
Pharmacological modulation of adenosine system: novel options for treatment of inflammatory bowel diseases 150
Protective effects of the combination Bifidobacterium longum plus lactoferrin against NSAID-induced enteropathy 150
Nonsteroidal anti-inflammatory drug-activated gene-1 plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer healing 149
Clinical evaluation of piroxicam-FDDF and azithromycin in the prevention of complications associated with impacted lower third molar extraction 148
Cholecystokinin CCK2 receptors mediate the peptide's inhibitory actions on the contractile activity of human distal colon via the nitric oxide pathway 148
Mild hypothyroidism anticipates and accelerates age-related endothelial dysfunction in rat mesenteric small arteries: role of inducibile NO synthase 146
Interplay between colonic inflammation and tachykininergic pathways in the onset of colonic dysmotility in a mouse model of diet-induced obesity 146
Enteric dysfunctions in experimental Parkinson's disease: alterations of excitatory cholinergic neurotransmission regulating colonic motility in rats 146
Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson’s disease before brain pathology 146
High Levels of β-Amyloid, Tau, and Phospho-Tau in Red Blood Cells as Biomarkers of Neuropathology in Senescence-Accelerated Mouse 145
Quantitative and qualitative changes of colonic myenteric ganglia in patients with ulcerative colitis 144
Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of iNOS and oxidative stress 144
Risankizumab for the treatment of moderate to severe psoriasis 144
Effects of L-DOPA/benserazide co-treatment on colonic excitatory cholinergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 144
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease 143
NSAID activated gene (NAG-1) plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer repair 143
Drug-induced taste and smell alterations: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting 143
CCK2 receptors mediate inhibitory effects of cholecystokinin on the motor activity of guinea-pig distal colon 142
Totale 17.635
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.321
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.321
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021996 0 0 0 0 0 0 70 124 216 189 86 311
2021/20221.993 36 97 62 114 377 282 79 118 109 79 138 502
2022/20232.877 314 380 206 287 292 362 32 234 500 49 189 32
2023/20242.504 243 251 298 196 380 405 59 108 104 93 123 244
2024/20256.578 76 245 106 404 574 722 602 304 694 865 687 1.299
2025/20264.605 533 852 1.033 634 837 651 65 0 0 0 0 0
Totale 27.813